Mintz Paul (CIK 1480208) reported 6 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-12-11). Recent activity: Buy AURX (50,000 shares), Sell AURX (9,091 shares), Buy AURX (50,000 shares), Sell AURX (9,091 shares), Buy AURX (87,500 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-12-11 | Nuo Therapeutics, Inc. (AURX) | Director | Buy | 50,000 | $20,000 |
| 2025-12-11 | Nuo Therapeutics, Inc. (AURX) | Director | Sell | 9,091 | $20,000 |
| 2025-12-11 | Nuo Therapeutics, Inc. (AURX) | Director | Buy | 50,000 | $20,000 |
| 2025-12-11 | Nuo Therapeutics, Inc. (AURX) | Director | Sell | 9,091 | $20,000 |
| 2025-08-04 | Nuo Therapeutics, Inc. (AURX) | Director | Buy | 87,500 | $35,000 |
| 2025-08-04 | Nuo Therapeutics, Inc. (AURX) | Director | Sell | 20,115 | $35,000 |
Source: SEC Form 4 filings · as of 2025-12-11